MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 59 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,604,225 | +27.2% | 1,243,585 | +30.2% | 0.00% | 0.0% |
| Q2 2023 | $1,260,694 | +71085.4% | 955,071 | -61.9% | 0.00% | 0.0% |
| Q1 2023 | $1,771 | +80.0% | 2,505,630 | +91.1% | 0.00% | 0.0% |
| Q4 2022 | $984 | -99.9% | 1,311,349 | +4.6% | 0.00% | 0.0% |
| Q3 2022 | $1,079,000 | +37.3% | 1,253,611 | +78.6% | 0.00% | – |
| Q2 2022 | $786,000 | -23.5% | 701,896 | -23.5% | 0.00% | -100.0% |
| Q1 2022 | $1,028,000 | -32.5% | 918,058 | -3.5% | 0.00% | 0.0% |
| Q4 2021 | $1,522,000 | -56.2% | 951,034 | -33.7% | 0.00% | -50.0% |
| Q3 2021 | $3,472,000 | -34.2% | 1,434,544 | -13.8% | 0.00% | -33.3% |
| Q2 2021 | $5,275,000 | -39.5% | 1,663,950 | -35.7% | 0.00% | -50.0% |
| Q1 2021 | $8,726,000 | +1412.3% | 2,589,367 | +1506.5% | 0.01% | – |
| Q4 2020 | $577,000 | – | 161,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |